Senate Bill Aims To Incentivize Generic Substitution In Medicaid
This article was originally published in The Pink Sheet Daily
Executive Summary
Bipartisan bill would rebate 50% of savings to states who improve generic utilization rates year-over-year through fiscal 2014.
You may also be interested in...
GPhA’s Deficit Reduction Proposals Focus On Medicare Low-Income Subsidy, REMS Policies
In letters to congressional leaders, generic drug trade group outlines six proposals that it says would save the government billions of dollars and lessen the impact of sequestration cuts.
Generics Industry Offers Substitution, Not Rebates, As Health Reform Savings Proposal
Giving states incentives to boost Medicaid's use of generic drugs would produce more savings than Sen. Baucus' rebate proposals, Teva argues.
Cancer-Genomics Firm Quanticel Debuts With Close Ties To Celgene, And An Exit In Mind
Celgene will get exclusive use of Quanticel's single-cell genomic analysis to tweak its clinical pipeline, and it also has exclusive options to acquire the venture-backed start-up.